AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vestova 0.25mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Cetrorelix (0.25mg)

Overview Vestova 0.25mg Injection

Ganirelix 0.25mg Injection, a GnRH antagonist, treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Home administration, if deemed appropriate, will be instructed by your doctor or nurse. Dosage and frequency vary depending on the treatment plan, determined by your physician to optimize results. Continue using this medication as prescribed. Common side effects include injection site reactions (redness, itching, burning), nausea, and vomiting. Rotate injection sites (abdomen) daily to minimize irritation. Seek immediate medical attention for dizziness, fainting, abdominal pain, and persistent vomiting. Before commencing treatment, disclose any pre-existing liver or kidney conditions, and inform your doctor about all other medications you are using, as drug interactions may impact efficacy.

Uses of Vestova 0.25mg Injection

Inability to conceive in women

Major Benefits of Vestova 0.25mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Vestova 0.25mg Injection:

  • Nausea
  • Ovarian hyperstimulation syndrome
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Irritation
  • Vomiting
  • Lower abdominal pain

How to use Vestova 0.25mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Vestova 0.25mg Injection works:

Women receiving infertility treatment may experience premature egg release, yielding eggs unsuitable for fertilization. Vestova 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing premature ovarian egg expulsion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of alcohol with Vestova 0.25mg Injection requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Administering Vestova 0.25mg Injection during pregnancy poses a considerable risk. Pregnant individuals should consult their physician; research involving pregnant women and animals reveals substantial adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Administering Vestova 0.25mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingSAFE

Driving ability is typically unaffected by Vestova 0.25mg Injection.

KidneyKidneyCAUTION

Administering Vestova 0.25mg Injection to individuals with impaired kidney function requires careful consideration. Dosage modification might be necessary. Physician consultation is advised. Nevertheless, Vestova 0.25mg Injection is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Administering Vestova 0.25mg Injection to individuals with hepatic impairment requires careful monitoring. Dosage modification for Vestova 0.25mg Injection may be necessary. Physician consultation is advised.

What if you forget to take Vestova 0.25mg Injection :

Should you forget a dose of Vestova 0.25mg Injection, seek your physician's advice.

Facts to Know About Vestova 0.25mg Injection

LabelValue
Pharmaceutical Classification Short-chain amino acid sequences
Addictive None.
Medication Classification ENDOCRINE SUBSTANCES
Mechanism of Action GnRH receptor blockers

FAQs on Vestova 0.25mg Injection

Ganirelix 0.25mg Injection (Vestova) is an injectable formulation employed in assisted reproductive technologies for women. This medication inhibits luteinizing hormone (LH) release, thereby preventing premature ovulation and allowing for optimal egg maturation. Its administration is typically part of a combined drug regimen.
Administered intravenously, this medication is exclusively provided in a hospital or clinic setting by qualified medical personnel. Follicular growth is tracked consistently throughout the patient's treatment. The treatment's length is determined by the individual's ovarian response.
Skin redness, possibly with swelling, is the most frequently reported reaction at the injection site. Headache and nausea are also possible. These side effects are usually short-lived; however, persistent symptoms warrant a physician consultation. Furthermore, ovarian hyperstimulation syndrome (OHSS), multiple pregnancies, and birth defects have been linked to this medication.
Vestova 0.25mg Injection
1,017
MRP 1,239
17% off